Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Embryonal Tumor, NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01417507
What this trial is testing

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

Who this might be right for
Adult Diffuse AstrocytomaAdult Mixed GliomaAdult Oligodendroglioma+4 more
Radiation Therapy Oncology Group 82
Testing effectiveness (Phase 2)Looking for participantsNCT03213002
What this trial is testing

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more
Northwell Health 67
Early research (Phase 1)Ended earlyNCT01103375
What this trial is testing

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Looking for participantsNCT07462507
What this trial is testing

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Who this might be right for
Central Nervous System CancerBrain Metastases
Washington University School of Medicine 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291105
What this trial is testing

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer
Vyriad, Inc. 87
Testing effectiveness (Phase 2)Ended earlyNCT00612222
What this trial is testing

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06678867
What this trial is testing

The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours

Who this might be right for
Brain Tumor
University College, London 80
Testing effectiveness (Phase 2)Study completedNCT00846456
What this trial is testing

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Who this might be right for
GlioblastomaBrain Tumor
Oslo University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03304639
What this trial is testing

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

Who this might be right for
Advanced Merkel Cell CarcinomaClinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Ended earlyNCT01721577
What this trial is testing

Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more
Rush University Medical Center 10
Not applicableStudy completedNCT01407731
What this trial is testing

Protein Expression in Human Neuroblastoma Tumor Samples

Who this might be right for
Neuroblastoma
Children's Oncology Group 20
Testing effectiveness (Phase 2)Ended earlyNCT00923247
What this trial is testing

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Who this might be right for
Medullary Thyroid Carcinoma
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT01138813
What this trial is testing

Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145)

Who this might be right for
Glioma
Merck Sharp & Dohme LLC 8
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Not applicableStudy completedNCT00125710
What this trial is testing

Comparative 2-D Tumor Analysis in Familial Gliomas

Who this might be right for
Malignant Glioma
AHS Cancer Control Alberta 5
Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Testing effectiveness (Phase 2)Study completedNCT00070096
What this trial is testing

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more
Memorial Sloan Kettering Cancer Center 29
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Next Page